These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 30771169)

  • 1. Stereotaxic Targeting of Alpha-Synuclein Pathology in Mouse Brain Using Preformed Fibrils.
    Zhang B; Kehm V; Gathagan R; Leight SN; Trojanowski JQ; Lee VM; Luk KC
    Methods Mol Biol; 2019; 1948():45-57. PubMed ID: 30771169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports.
    Lashuel HA
    Neurobiol Dis; 2020 Jul; 141():104876. PubMed ID: 32339655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust Central Nervous System Pathology in Transgenic Mice following Peripheral Injection of α-Synuclein Fibrils.
    Ayers JI; Brooks MM; Rutherford NJ; Howard JK; Sorrentino ZA; Riffe CJ; Giasson BI
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27852849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models.
    Mavroeidi P; Arvanitaki F; Karakitsou AK; Vetsi M; Kloukina I; Zweckstetter M; Giller K; Becker S; Sorrentino ZA; Giasson BI; Jensen PH; Stefanis L; Xilouri M
    Acta Neuropathol; 2019 Sep; 138(3):415-441. PubMed ID: 31011860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein (αSyn) Preformed Fibrils Induce Endogenous αSyn Aggregation, Compromise Synaptic Activity and Enhance Synapse Loss in Cultured Excitatory Hippocampal Neurons.
    Wu Q; Takano H; Riddle DM; Trojanowski JQ; Coulter DA; Lee VM
    J Neurosci; 2019 Jun; 39(26):5080-5094. PubMed ID: 31036761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Synuclein Propagation Mouse Models of Parkinson's Disease.
    Uemura N; Ueda J; Okuda S; Sawamura M; Takahashi R
    Methods Mol Biol; 2021; 2322():119-130. PubMed ID: 34043198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats.
    Van Den Berge N; Ferreira N; Gram H; Mikkelsen TW; Alstrup AKO; Casadei N; Tsung-Pin P; Riess O; Nyengaard JR; Tamgüney G; Jensen PH; Borghammer P
    Acta Neuropathol; 2019 Oct; 138(4):535-550. PubMed ID: 31254094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson's disease.
    Geibl FF; Henrich MT; Xie Z; Zampese E; Ueda J; Tkatch T; Wokosin DL; Nasiri E; Grotmann CA; Dawson VL; Dawson TM; Chandel NS; Oertel WH; Surmeier DJ
    Mol Neurodegener; 2024 Oct; 19(1):69. PubMed ID: 39379975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity.
    Luna E; Decker SC; Riddle DM; Caputo A; Zhang B; Cole T; Caswell C; Xie SX; Lee VMY; Luk KC
    Acta Neuropathol; 2018 Jun; 135(6):855-875. PubMed ID: 29502200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice.
    Karampetsou M; Ardah MT; Semitekolou M; Polissidis A; Samiotaki M; Kalomoiri M; Majbour N; Xanthou G; El-Agnaf OMA; Vekrellis K
    Sci Rep; 2017 Nov; 7(1):16533. PubMed ID: 29184069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolysis of α-synuclein fibrils in the lysosomal pathway limits induction of inclusion pathology.
    Sacino AN; Brooks MM; Chakrabarty P; Saha K; Khoshbouei H; Golde TE; Giasson BI
    J Neurochem; 2017 Feb; 140(4):662-678. PubMed ID: 27424880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propagation of pathological α-synuclein in marmoset brain.
    Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M
    Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease.
    Price DL; Koike MA; Khan A; Wrasidlo W; Rockenstein E; Masliah E; Bonhaus D
    Sci Rep; 2018 Nov; 8(1):16165. PubMed ID: 30385782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve.
    Uemura N; Yagi H; Uemura MT; Hatanaka Y; Yamakado H; Takahashi R
    Mol Neurodegener; 2018 May; 13(1):21. PubMed ID: 29751824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lewy body-associated proteins: victims, instigators, or innocent bystanders? The case of AIMP2 and alpha-synuclein.
    Lashuel HA; Novello S
    Neurobiol Dis; 2021 Aug; 156():105417. PubMed ID: 34102275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils.
    Dhillon JS; Trejo-Lopez JA; Riffe C; Levites Y; Sacino AN; Borchelt DR; Yachnis AY; Giasson BI
    Acta Neuropathol Commun; 2019 May; 7(1):80. PubMed ID: 31109378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow Progressive Accumulation of Oligodendroglial Alpha-Synuclein (α-Syn) Pathology in Synthetic α-Syn Fibril-Induced Mouse Models of Synucleinopathy.
    Uemura N; Uemura MT; Lo A; Bassil F; Zhang B; Luk KC; Lee VM; Takahashi R; Trojanowski JQ
    J Neuropathol Exp Neurol; 2019 Oct; 78(10):877-890. PubMed ID: 31504665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity.
    Villar-Piqué A; Lopes da Fonseca T; Sant'Anna R; Szegö ÉM; Fonseca-Ornelas L; Pinho R; Carija A; Gerhardt E; Masaracchia C; Abad Gonzalez E; Rossetti G; Carloni P; Fernández CO; Foguel D; Milosevic I; Zweckstetter M; Ventura S; Outeiro TF
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6506-E6515. PubMed ID: 27708160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes.
    Chu Y; Muller S; Tavares A; Barret O; Alagille D; Seibyl J; Tamagnan G; Marek K; Luk KC; Trojanowski JQ; Lee VMY; Kordower JH
    Brain; 2019 Nov; 142(11):3565-3579. PubMed ID: 31580415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy.
    Moors TE; Maat CA; Niedieker D; Mona D; Petersen D; Timmermans-Huisman E; Kole J; El-Mashtoly SF; Spycher L; Zago W; Barbour R; Mundigl O; Kaluza K; Huber S; Hug MN; Kremer T; Ritter M; Dziadek S; Geurts JJG; Gerwert K; Britschgi M; van de Berg WDJ
    Acta Neuropathol; 2021 Sep; 142(3):423-448. PubMed ID: 34115198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.